Description

Pparδ Agonist CAS NO 942594-93-6 is a high-purity, small-molecule compound designed to selectively activate the Peroxisome Proliferator-Activated Receptor Delta (PPARδ). This specificity makes it a critical tool for metabolic and inflammatory pathway research, offering valuable insights into energy homeostasis and cellular regulation. It is primarily utilized by pharmaceutical R&D teams, academic research institutions, and biotechnology companies engaged in drug discovery for metabolic disorders, cardiovascular diseases, and muscular dystrophies.

Application

• Pharmaceutical Research & Development: Serves as a reference standard and active pharmacological agent in the discovery and validation of novel therapeutics targeting PPARδ.
• Metabolic Disease Studies: Used in in vitro and in vivo models to investigate its role in glucose metabolism, lipid oxidation, and insulin sensitization for conditions like type 2 diabetes and obesity.
• Cardiovascular Research: Applied in studies exploring the cardioprotective effects of PPARδ activation, including research on atherosclerosis and heart failure.
• Muscle Physiology & Exercise Mimetics: Investigated for its potential to enhance endurance, muscle fiber type switching, and mitochondrial biogenesis in skeletal muscle.
• Inflammation & Immunology: Utilized to study the anti-inflammatory pathways mediated by PPARδ in macrophages and other immune cells.
• Biochemical Assay Development: Acts as a key control compound in high-throughput screening (HTS) and binding assays to identify and characterize new PPARδ modulators.
• Academic & Preclinical Studies: Supports fundamental biological research in university and institutional labs focused on nuclear receptor signaling and gene expression.

Basic Information

Product Name	Pparδ Agonist
CAS No.	942594-93-6
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	PPARδ Agonist; PPAR Delta Agonist; GW 501516; GW501516; Endurobol; GW-501,516; Peroxisome proliferator-activated receptor delta agonist; Cardarine
EINECS	Contact for details

Quality Control

Our Pparδ Agonist is manufactured under strict quality management systems to ensure batch-to-batch consistency and reliability for critical research applications. Each lot undergoes comprehensive analytical testing, including identity confirmation by spectroscopic methods and purity assessment by high-performance liquid chromatography (HPLC). A Certificate of Analysis (COA) detailing all specifications and test results is provided with every shipment to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label or COA. For long-term storage, consider storing desiccated at -20°C. Handle and store in accordance with good laboratory practices.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC/MS)	Conforms
Purity (HPLC)	≥98.0%
Related Substances (HPLC)	Individual impurity ≤0.5%; Total impurities ≤2.0%
Water Content (KF)	≤0.5%
Residual Solvents (GC)	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.